Cutaneous group B streptococcal infection

Cutaneous group B streptococcal infection
Synonyms	Streptococcus agalactiae skin infection
Pronounce	N/A
Specialty	N/A
Symptoms	Cellulitis, erysipelas, abscesses, ulcers
Complications	Sepsis, necrotizing fasciitis
Onset	Any age, more common in neonates and elderly
Duration	Varies, depending on treatment
Types	N/A
Causes	Streptococcus agalactiae
Risks	Diabetes mellitus, immunocompromised state, pregnancy
Diagnosis	Clinical diagnosis, bacterial culture
Differential diagnosis	Staphylococcal skin infection, cellulitis from other causes
Prevention	Good hygiene, managing chronic conditions
Treatment	Antibiotics such as penicillin, amoxicillin
Medication	Antibiotics
Prognosis	Good with treatment, but can be severe in immunocompromised
Frequency	Less common than other streptococcal infections
Deaths	N/A

Cutaneous Group B Streptococcal Infection is a type of bacterial infection caused by the bacterium Streptococcus agalactiae, commonly known as Group B Streptococcus (GBS). This condition specifically affects the skin, leading to various symptoms and complications if not treated promptly. GBS is known for its role in neonatal infections but can also affect adults, particularly those with compromised immune systems or existing skin damage.

Symptoms and Diagnosis

The symptoms of cutaneous GBS infection can vary but often include redness, swelling, tenderness, and the presence of blisters or ulcers on the skin. In severe cases, the infection can lead to systemic symptoms such as fever, chills, and malaise. Diagnosis typically involves the collection of a skin swab or tissue biopsy, which is then cultured to identify the presence of GBS. In some cases, blood tests may also be conducted to check for signs of systemic infection.

Transmission and Risk Factors

Cutaneous GBS infection is primarily transmitted through direct contact with the bacteria, which can occur through breaks in the skin or mucous membranes. Individuals at higher risk include newborns, particularly those born to mothers who are colonized with GBS, and adults with chronic health conditions such as diabetes or those with weakened immune systems. Skin injuries, surgical wounds, and the use of invasive medical devices can also increase the risk of infection.

Treatment and Prevention

Treatment for cutaneous GBS infection typically involves the use of antibiotics to eliminate the bacteria. In cases of mild skin infection, oral antibiotics may be sufficient, while more severe or systemic infections may require intravenous administration. Prevention strategies include routine screening for GBS colonization in pregnant women and the use of intrapartum antibiotic prophylaxis to prevent neonatal infection. Good wound care and hygiene practices can also reduce the risk of cutaneous GBS infection in adults.

Complications

If left untreated, cutaneous GBS infection can lead to serious complications, including the spread of the infection to deeper tissues or the bloodstream, resulting in conditions such as cellulitis, necrotizing fasciitis, or bacteremia. These complications can be life-threatening and require immediate medical intervention.